Experiments on the Nature of the Prothrombin‐Converting Principle: Alteration of Proaccelerin Thrombin

An incubation mixture of activated Stuart factor, calcium, phospholipid and proaccelerin caused the generation of thrombin from prothrombin. The activity of this prothrombin‐ converting principle was measured by the rate at which it converted prothrombin to thrombin. In the absence of thrombin in the incubation mixture, a lag phase, following addition of the prothrombin‐converting principle to prothrombin, was observed before thrombin formation occurred. But when a trace of thrombin was added to the incubation mixture, it converted the principle into an active form, causing the immediate formation of thrombin from prothrombin without any delay. It was demonstrated that thrombin had this action upon the prothrombin‐converting principle by changing proaccelerin into a more active form.

[1]  O. Ratnoff,et al.  The activation of proaccelerin by bovine thrombokinase (with notes on the antithrombic activity of phenylmethyl sulfonylfluoride). , 1966, Blood.

[2]  J. Mustard,et al.  The Activation of Factor VIII by Thrombin , 1965 .

[3]  D. Bergsagel,et al.  The Activation of Proaccelerin , 1965, British journal of haematology.

[4]  O. Ratnoff,et al.  The Role of Proaccelerin in Human Blood Coagulation. Evidence that Proaccelerin Is Converted to a Prothrombin-converting Principle by Activated Stuart Factor: With Notes on the Anticoagulant Action of Soybean Trypsin Inhibitor, Protamine Sulfate, and Hexadimethrine Bromide. , 1965, The Journal of clinical investigation.

[5]  R. G. Macfarlane,et al.  The Interaction of Factors VIII and IX , 1964 .

[6]  J. Olwin,et al.  Autoprothrombin C from a Commercial Thrombin Product , 1964, Nature.

[7]  D. Papahadjopoulos,et al.  PURIFICATION AND PROPERTIES OF BOVINE FACTOR V: A CHANGE OF MOLECULAR SIZE DURING BLOOD COAGULATION. , 1964, Biochemistry.

[8]  S. Rapaport,et al.  The importance of activation of antihemophilic globulin and proaccelerin by traces of thrombin in the generation of intrinsic prothrombinase activity. , 1963, Blood.

[9]  R. G. Macfarlane The Coagulant Action of Russell's Viper Venom; The Use of Antivenom in Defining its Reaction with a Serum Factor , 1961, British journal of haematology.

[10]  J. Peden,et al.  The coagulation of blood by Russell's viper venom; a reaction between Russell's viper venom and beef serum factors. , 1958, The Journal of laboratory and clinical medicine.

[11]  H. Hortling,et al.  The nembutal metabolic rate as an aid in the study of thyroid function. , 1957, Scandinavian journal of clinical and laboratory investigation.

[12]  A. Douglas Factor‐V Consumption During Blood Coagulation , 1956, British journal of haematology.

[13]  A. G. Ware,et al.  Chromatographic purification of human serum accelerator globulin. , 1956, The Journal of clinical investigation.

[14]  R. Hardisty The Reaction of Blood Coagulation Factors with Brain Extract , 1955, British journal of haematology.

[15]  P. S. Rasmussen Purification of thrombin by chromatography. , 1955, Biochimica et biophysica acta.

[16]  A. G. Ware,et al.  Note on the mechanism of activation of human accelerator globulin by thrombin. , 1955, Biochimica et biophysica acta.

[17]  W. N. Bell,et al.  A Brain Extract as a Substitute for Platelet Suspensions in the Thromboplastin Generation Test , 1954, Nature.

[18]  M. L. Lewis,et al.  The mechanism of action of human accelerator globulin and its relation to other clotting factors. , 1954, Blood.

[19]  O. Ratnoff,et al.  THE INFLUENCE OF CALCIUM IONS ON THE INACTIVATION OF HUMAN COMPLEMENT AND ITS COMPONENTS BY PLASMIN , 1953, The Journal of experimental medicine.

[20]  P. Frick,et al.  Congenital familial deficiency of the stable prothrombin conversion factor; restudy of case originally reported as idiopathic hypoprothrombinemia. , 1953, The Journal of laboratory and clinical medicine.

[21]  C. Hussey,et al.  Activation of thromboplastinogen by thrombin. , 1953, The American journal of physiology.

[22]  P. Owren Prothrombin and accessory factors; clinical significance. , 1953, The American journal of medicine.

[23]  A. S. Douglas,et al.  The formation of thromboplastin in human blood , 1953, The Journal of physiology.

[24]  B. Alexander,et al.  The labile factor of prothrombin conversion: its consumption under normal and pathological conditions affecting blood coagulation. , 1951, The Journal of clinical investigation.

[25]  W. Seegers,et al.  SERUM AC-GLOBULIN: FORMATION FROM PLASMA AC-GLOBULIN; ROLE IN BLOOD COAGULATION; PARTIAL PURIFICATION; PROPERTIES; AND QUANTITATIVE DETERMINATION , 1948 .

[26]  W. Seegers,et al.  The Function of Ac-Globulin in Blood Clotting. , 1947, Science.

[27]  A. Glazko EFFECT OF BLOOD PROTEASE AND TRYPSIN INHIBITOR ON THE CLOTTING MECHANISM. , 1947, The Journal of clinical investigation.

[28]  J. Pilling,et al.  Anticoagulant action of soya-bean trypsin-inhibitor. , 1946, Lancet.

[29]  Tagnon Hj,et al.  Anticoagulant activity of the trypsin inhibitor from soya bean flour. , 1946 .